Definitive Healthcare Corp.

NASDAQ:DH

Medical - Healthcare Information Services

Healthcare
$1.34 +1.85%

+$0.01 today

Market cap
$143.60M
Beta
1.33
P/E (TTM)
-0.5
EPS (TTM)
-$1.63
52W Low $0.77High $4.70

Volume 0.43M

Average 0.32M

DH Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Definitive Healthcare Corp.NASDAQ: DH

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash turns negative

Q1 FY2026 net change in cash was -$5.98M, compared with $721K a year earlier. Trailing-twelve-month net change in cash was $51.55M.

Context

  • Net change in cash amounted to 24.1% of revenue in FY2025, up 14.0 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly net change in cash holds near -$5.98M or moves back toward the trailing-twelve-month quarterly average of $12.89M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$5.98M-110.8% QoQ
Last fiscal yearDec 2025
$58.25M+327.6% YoY
LTMMar 2026
$51.55M+48994.3% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-929.3%——
1 year+327.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
58.25M USD
Year-over-year change
+327.6%
4-year CAGR
-36.7%

Net Change in Cash vs competitors

How DH compares with its peers on the latest reported figures

  • DH's LTM Mar 2026 net change in cash of $51.55M is the largest of the 10 companies compared; the peer median is $2.8M.
  • Its year-over-year change of +48994.3% is the highest of 10, against a peer median of -65.0%.
  • Net change in cash amounts to 21.6% of revenue for DH, versus a peer median of 7.3%.
DH Competitors Peer median
Net Change in Cash for DH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHDefinitive Healthcare Corp.LTM Mar 2026$51.55M +48994.3%—21.6%
NAKANakamoto Inc.LTM Mar 2026$34.16M +3903.5%+503.9%871.5%
TBRGTruBridge, Inc.LTM Mar 2026$25.3M +321.0%—7.3%
KYTXKyverna Therapeutics, Inc.LTM Mar 2026$24.68M -85.3%——
EDITEditas Medicine, Inc.LTM Mar 2026$16.25M -123.4%—42.0%
CABACabaletta Bio, Inc.LTM Mar 2026$15.2M -65.0%+25.9%—
SLPSimulations Plus, Inc.LTM Feb 2026$14.74M +156.6%+12.1%18.3%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$3.14M -91.1%-32.0%3.9%
SPOKSpok Holdings, Inc.LTM Mar 2026$2.8M -19.4%-24.1%2.0%
NRCNational Research CorporationLTM Mar 2026$45K -94.4%-85.3%0.0%
Peer median (excluding DH) $2.8M-65.0%-6.0%7.3%

Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(62.32M)(22.26M)(202.39M)(591.45M)(199.3M)
Depreciation & Amortization59.95M56.9M51.75M51.67M56.11M
Deferred Income Tax(587K)(26.67M)(18.71M)(119.58M)(10.88M)
Stock-Based Compensation9.96M36.43M48.74M38.09M29.14M
Change in Working Capital(2.51M)(21.95M)(30.39M)(25.93M)(9.42M)
Accounts Receivables(10.73M)(13.22M)811K5.69M1.38M
Inventory00000
Accounts Payables3.42M358K1.33M(5.46M)(1.09M)
Other Working Capital4.79M(9.09M)(32.53M)(26.17M)(9.71M)
Other Non-Cash Items20.73M13.12M192.19M705.4M188.12M
Operating Cash Flow25.21M35.58M41.19M58.2M53.78M
Capital Expenditures(6.73M)(8.33M)(2.98M)(12.34M)(16.72M)
Acquisitions (Net)(40M)(56.3M)(45.02M)(13.53M)0
Purchases of Investments0(337.96M)(259.21M)(304.3M)(64.07M)
Sales of Investments0153.68M275.43M303.77M234.66M
Other Investing Activities00000
Investing Cash Flow(46.73M)(248.9M)(31.78M)(26.41M)153.88M
Debt Repayment(199.46M)(6.88M)(8.59M)(13.75M)(79.47M)
Common Stock Issued834.95M(1.73M)(30K)00
Common Stock Repurchased(231.77M)00(22.37M)(49.45M)
Dividends Paid(8.13M)(12.87M)(12.28M)(5.14M)(3.15M)
Other Financing Activities(11.22M)(5.22M)(4.68M)(15.5M)(18.72M)
Financing Cash Flow384.37M(26.7M)(25.58M)(56.75M)(150.79M)
Effect of Forex Changes(129K)(544K)218K(636K)1.39M
Net Change in Cash362.72M(240.56M)(15.96M)(25.6M)58.25M
Free Cash Flow18.48M27.25M38.21M45.85M37.06M

Definitive Healthcare Corp.

NASDAQ:DH

Intrinsic Alpha fair value

Locked

Current Price

$1.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.